Lycia Therapeutics, Inc. (LYCA) stock
LYCANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$31.35+0.43 (+1.39%)
Close on Nov 18, 2026Market cap –P/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Trading
- Previous close
- $30.92
- Open
- $30.60
- Day's range
- $30.45 – $32.85
- Volume
- 383,617
- Average volume (20 days)
- 441,424
Lycia Therapeutics stock: common questions
What is Lycia Therapeutics's stock price?
LYCA closed at $31.35 on Nov 18, 2026, up 1.39% on the day.
Does Lycia Therapeutics pay a dividend?
No. Lycia Therapeutics has not paid a cash dividend over the last twelve months.
Who are Lycia Therapeutics's competitors?
Companies most similar to Lycia Therapeutics by business, industry and size include AMGN, GILD, MRNA, BIIB, BNTX.
See a number that looks wrong?